Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier

Cancer Invest. 1984;2(1):39-49. doi: 10.3109/07357908409020285.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antibody-Dependent Cell Cytotoxicity / drug effects
  • Candidiasis / drug therapy
  • Cytotoxicity, Immunologic / drug effects*
  • Humans
  • Killer Cells, Natural / immunology
  • Leukemia L1210 / drug therapy
  • Leukemia L1210 / immunology
  • Leukemia P388 / drug therapy
  • Leukemia P388 / immunology
  • Leukemia, Experimental / drug therapy*
  • Leukemia, Experimental / immunology
  • Lymphocyte Activation / drug effects
  • Macrophages / immunology
  • Melanoma / drug therapy
  • Melanoma / immunology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred CBA
  • Mice, Inbred DBA
  • Neoplasm Transplantation
  • Neutrophils / immunology
  • Phagocytosis
  • Receptors, Cell Surface / immunology
  • Receptors, Immunologic*
  • Tuftsin / immunology*
  • Tuftsin / isolation & purification
  • Tuftsin / pharmacology
  • Tuftsin / therapeutic use

Substances

  • Receptors, Cell Surface
  • Receptors, Immunologic
  • tuftsin receptor
  • Tuftsin